Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Autonomix Medical, Inc.

  • THE WOODLANDS, Texas
  • Public · NASDAQ: AMIX
  • 11 employees
$4.7MMarket cap
$0Revenue · FY2026
-$16.7MNet income
11Employees
AMIXNASDAQ
2024IPO

About Autonomix Medical, Inc.

Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2026
$0
Net income
-$16.7M
Total assets
$7.6M
Market cap
$4.7M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: AMIX

15-minute delayed · data by Polygon.io

Market cap
$4.7M
Open
Day range
Prev close
Volume
IPO date
Jan 29, 2024

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Autonomix Medical, Inc..

Write a review
Explore

Similar companies

Browse all →